Ozempic Injury Suits Consolidated In Eastern Pa. MDL
The Judicial Panel on Multidistrict Litigation has moved 55 MDL cases over Ozempic and similar drugs to the Eastern District of Pennsylvania, centralizing the litigation that claims Novo Nordisk A/S and...To view the full article, register now.
Already a subscriber? Click here to view full article